Isosulfan blue 1% vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FKKH2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,293
Award facts
- Contract value 100% obligated
- $22,292.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,292.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Isosulfan Blue 1% in 5ML vials. The contract, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating that DMS Pharmaceutical competed in an unrestricted procurement environment. This delivery order is issued under DMS Pharmaceutical's larger Indefinite Delivery Contract (IDC) with the DLA, specifically the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a ceiling value of $499,999,999 and completion date of December 31, 2036.
The PPV-G GEN V represents a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical supply chain operations for Department of Defense military healthcare facilities globally. Under this broader vehicle, DMS Pharmaceutical Group serves as one of multiple regional prime vendor contractors authorized to provide comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables. The company's established performance across numerous delivery orders demonstrates its capability to support the specialized and diverse pharmaceutical requirements of the federal military medical system, with its small business status enabling competitive participation in the defense pharmaceutical procurement market.
Quick answers
Who was awarded contract SPE2DR26FKKH2?
SPE2DR26FKKH2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FKKH2 worth?
The government has obligated $22,293 on SPE2DR26FKKH2.
Is contract SPE2DR26FKKH2 an order under another contract?
Yes. SPE2DR26FKKH2 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKH2 competed?
The extent of competition for SPE2DR26FKKH2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award